179 related articles for article (PubMed ID: 8269592)
61. Biotransformation of letrozole in rat liver microsomes: effects of gender and tamoxifen.
Tao X; Piao H; Canney DJ; Borenstein MR; Nnane IP
J Pharm Biomed Anal; 2007 Feb; 43(3):1078-85. PubMed ID: 17045772
[TBL] [Abstract][Full Text] [Related]
62. Effects of phenobarbital and 3-methylcholanthrene induction on the formation of three glucuronide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, NNK.
Murphy SE; Nunes MG; Hatala MA
Chem Biol Interact; 1997 Mar; 103(3):153-66. PubMed ID: 9134006
[TBL] [Abstract][Full Text] [Related]
63. Oxidative activation of the thiophene ring by hepatic enzymes. Hydroxylation and formation of electrophilic metabolites during metabolism of tienilic acid and its isomer by rat liver microsomes.
Dansette PM; Amar C; Smith C; Pons C; Mansuy D
Biochem Pharmacol; 1990 Mar; 39(5):911-8. PubMed ID: 2310416
[TBL] [Abstract][Full Text] [Related]
64. Oxazaphosphorines: new therapeutic strategies for an old class of drugs.
Giraud B; Hebert G; Deroussent A; Veal GJ; Vassal G; Paci A
Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):919-38. PubMed ID: 20446865
[TBL] [Abstract][Full Text] [Related]
65. Role of guinea pig and rabbit hepatic aldehyde oxidase in oxidative in vitro metabolism of cinchona antimalarials.
Beedham C; al-Tayib Y; Smith JA
Drug Metab Dispos; 1992; 20(6):889-95. PubMed ID: 1362942
[TBL] [Abstract][Full Text] [Related]
66. Quantification of dimethyl-ifosfamide and its N-deschloropropylated metabolites in mouse plasma by liquid chromatography-tandem mass spectrometry.
Deroussent A; Rodriguez S; Martelli S; Seck A; Dubus-Daudigeos E; Desmaële D; Vassal G; Paci A
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(11-12):743-50. PubMed ID: 21377940
[TBL] [Abstract][Full Text] [Related]
67. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.
Marinello AJ; Bansal SK; Paul B; Koser PL; Love J; Struck RF; Gurtoo HL
Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709
[TBL] [Abstract][Full Text] [Related]
68. Characterization of the in vitro metabolites of idelalisib in liver microsomes and interspecies comparison.
Chen CM; Wu WB; Chen JF; Chen Y
J Pharm Biomed Anal; 2019 Jan; 162():249-256. PubMed ID: 30268993
[TBL] [Abstract][Full Text] [Related]
69. High-performance liquid chromatographic-fluorescent method to determine chloroacetaldehyde, a neurotoxic metabolite of the anticancer drug ifosfamide, in plasma and in liver microsomal incubations.
Huang Z; Waxman DJ
Anal Biochem; 1999 Aug; 273(1):117-25. PubMed ID: 10452807
[TBL] [Abstract][Full Text] [Related]
70. In vitro studies on the oxidative metabolism of 20(s)-ginsenoside Rh2 in human, monkey, dog, rat, and mouse liver microsomes, and human liver s9.
Li L; Chen X; Zhou J; Zhong D
Drug Metab Dispos; 2012 Oct; 40(10):2041-53. PubMed ID: 22829543
[TBL] [Abstract][Full Text] [Related]
71. Activation of the anticancer prodrugs cyclophosphamide and ifosfamide: identification of cytochrome P450 2B enzymes and site-specific mutants with improved enzyme kinetics.
Chen CS; Lin JT; Goss KA; He YA; Halpert JR; Waxman DJ
Mol Pharmacol; 2004 May; 65(5):1278-85. PubMed ID: 15102956
[TBL] [Abstract][Full Text] [Related]
72. Phase I metabolism of ganstigmine. Rat, dog, monkey and human liver microsomal extracts investigated by liquid chromatography electrospray tandem mass spectrometry.
Catinella S; Pelizzi N; Puccini P; Marchetti S; Zanol M; Acerbi D; Ventura P
J Mass Spectrom; 2001 Dec; 36(12):1287-93. PubMed ID: 11754120
[TBL] [Abstract][Full Text] [Related]
73. Comparative study on human pharmacokinetics of activated ifosfamide and cyclophosphamide by a modified fluorometric test.
Wagner T; Heydrich D; Jork T; Voelcker G; Hohorst HJ
J Cancer Res Clin Oncol; 1981; 100(1):95-104. PubMed ID: 7240346
[TBL] [Abstract][Full Text] [Related]
74. In vitro biotransformation and investigation of metabolic enzymes possibly responsible for the metabolism of bisdesoxyolaquindox in the liver fractions of rats, chicken, and pigs.
Liu ZY; Chen DM; Huang LL; Tao YF; Yao M; Yuan ZH
Toxicology; 2011 Jan; 279(1-3):155-66. PubMed ID: 20955753
[TBL] [Abstract][Full Text] [Related]
75. Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide.
Walker D; Flinois JP; Monkman SC; Beloc C; Boddy AV; Cholerton S; Daly AK; Lind MJ; Pearson AD; Beaune PH
Biochem Pharmacol; 1994 Mar; 47(7):1157-63. PubMed ID: 8161344
[TBL] [Abstract][Full Text] [Related]
76. Renal clearance of ifosfamide.
Springate J; Zamlauski-Tucker MJ; Lu H; Chan KK
Drug Metab Dispos; 1997 Sep; 25(9):1081-2. PubMed ID: 9311624
[TBL] [Abstract][Full Text] [Related]
77. New ifosfamide analogs designed for lower associated neurotoxicity and nephrotoxicity with modified alkylating kinetics leading to enhanced in vitro anticancer activity.
Storme T; Deroussent A; Mercier L; Prost E; Re M; Munier F; Martens T; Bourget P; Vassal G; Royer J; Paci A
J Pharmacol Exp Ther; 2009 Feb; 328(2):598-609. PubMed ID: 19017849
[TBL] [Abstract][Full Text] [Related]
78. In vitro and in vivo metabolism of desogestrel in several species.
Verhoeven CH; Krebbers SF; Wagenaars GN; Vos RM
Drug Metab Dispos; 1998 Sep; 26(9):927-36. PubMed ID: 9733673
[TBL] [Abstract][Full Text] [Related]
79. Modulation of the control of mutagenic metabolites derived from cyclophosphamide and ifosfamide by stimulation of protein kinase A.
Oesch-Bartlomowicz B; Vogel S; Arens HJ; Oesch F
Mutat Res; 1990 Oct; 232(2):305-12. PubMed ID: 2170835
[TBL] [Abstract][Full Text] [Related]
80. Comutagenesis-IV in vitro metabolism of the comutagen 2-amino-3-methylpyridine: species differences and metabolic interaction with norharman.
Altuntas TG; Gorrod JW
Anticancer Res; 1997; 17(6D):4479-82. PubMed ID: 9494554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
